nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Thalidomide—leprosy	0.28	0.508	CbGbCtD
Guanabenz—CYP1A2—Rifampicin—leprosy	0.272	0.492	CbGbCtD
Guanabenz—Toxic skin eruption—Thalidomide—leprosy	0.0281	0.0653	CcSEcCtD
Guanabenz—NISCH—Menadione—Thalidomide—leprosy	0.0179	1	CbGdCrCtD
Guanabenz—Swelling face—Dapsone—leprosy	0.0167	0.0389	CcSEcCtD
Guanabenz—Peritonitis—Thalidomide—leprosy	0.0161	0.0375	CcSEcCtD
Guanabenz—Hypoproteinaemia—Thalidomide—leprosy	0.0139	0.0323	CcSEcCtD
Guanabenz—Electrolyte imbalance—Thalidomide—leprosy	0.00976	0.0227	CcSEcCtD
Guanabenz—Ascites—Thalidomide—leprosy	0.00897	0.0209	CcSEcCtD
Guanabenz—Raised liver function tests—Thalidomide—leprosy	0.00883	0.0205	CcSEcCtD
Guanabenz—Hernia—Thalidomide—leprosy	0.0087	0.0202	CcSEcCtD
Guanabenz—Skin exfoliation—Dapsone—leprosy	0.00761	0.0177	CcSEcCtD
Guanabenz—Gastric ulcer—Thalidomide—leprosy	0.00702	0.0163	CcSEcCtD
Guanabenz—Enlargement abdomen—Thalidomide—leprosy	0.00678	0.0158	CcSEcCtD
Guanabenz—Psoriasis—Thalidomide—leprosy	0.00649	0.0151	CcSEcCtD
Guanabenz—Hypomagnesaemia—Thalidomide—leprosy	0.00642	0.0149	CcSEcCtD
Guanabenz—Nail disorder—Thalidomide—leprosy	0.00629	0.0146	CcSEcCtD
Guanabenz—Intestinal obstruction—Thalidomide—leprosy	0.00598	0.0139	CcSEcCtD
Guanabenz—Burning sensation—Thalidomide—leprosy	0.00587	0.0136	CcSEcCtD
Guanabenz—Hypercalcaemia—Thalidomide—leprosy	0.00587	0.0136	CcSEcCtD
Guanabenz—Lung disorder—Thalidomide—leprosy	0.00576	0.0134	CcSEcCtD
Guanabenz—Skin ulcer—Thalidomide—leprosy	0.00524	0.0122	CcSEcCtD
Guanabenz—Influenza—Dapsone—leprosy	0.005	0.0116	CcSEcCtD
Guanabenz—Accidental injury—Thalidomide—leprosy	0.00461	0.0107	CcSEcCtD
Guanabenz—Skin discolouration—Thalidomide—leprosy	0.00451	0.0105	CcSEcCtD
Guanabenz—Thinking abnormal—Thalidomide—leprosy	0.00445	0.0104	CcSEcCtD
Guanabenz—Hypocalcaemia—Thalidomide—leprosy	0.00445	0.0104	CcSEcCtD
Guanabenz—Oliguria—Thalidomide—leprosy	0.00443	0.0103	CcSEcCtD
Guanabenz—Leukocytosis—Thalidomide—leprosy	0.00434	0.0101	CcSEcCtD
Guanabenz—Bone pain—Thalidomide—leprosy	0.00426	0.0099	CcSEcCtD
Guanabenz—Neck pain—Thalidomide—leprosy	0.00413	0.0096	CcSEcCtD
Guanabenz—Skin exfoliation—Thalidomide—leprosy	0.00389	0.00905	CcSEcCtD
Guanabenz—Tinnitus—Dapsone—leprosy	0.00373	0.00867	CcSEcCtD
Guanabenz—Rash maculo-papular—Thalidomide—leprosy	0.00371	0.00862	CcSEcCtD
Guanabenz—Pulmonary oedema—Thalidomide—leprosy	0.00363	0.00844	CcSEcCtD
Guanabenz—Hyperkinesia—Thalidomide—leprosy	0.00356	0.00827	CcSEcCtD
Guanabenz—Mental disability—Thalidomide—leprosy	0.00354	0.00823	CcSEcCtD
Guanabenz—Erythema—Dapsone—leprosy	0.00348	0.0081	CcSEcCtD
Guanabenz—Diabetes mellitus—Thalidomide—leprosy	0.0034	0.00791	CcSEcCtD
Guanabenz—Eczema—Thalidomide—leprosy	0.00329	0.00766	CcSEcCtD
Guanabenz—Vision blurred—Dapsone—leprosy	0.00328	0.00763	CcSEcCtD
Guanabenz—Injury—Thalidomide—leprosy	0.00322	0.00749	CcSEcCtD
Guanabenz—Dermatitis exfoliative—Thalidomide—leprosy	0.00314	0.00729	CcSEcCtD
Guanabenz—Dermatitis bullous—Thalidomide—leprosy	0.0031	0.0072	CcSEcCtD
Guanabenz—Cough—Dapsone—leprosy	0.00304	0.00706	CcSEcCtD
Guanabenz—Hypoglycaemia—Thalidomide—leprosy	0.00303	0.00705	CcSEcCtD
Guanabenz—Cardiac failure—Thalidomide—leprosy	0.00303	0.00705	CcSEcCtD
Guanabenz—Hyponatraemia—Thalidomide—leprosy	0.00297	0.00691	CcSEcCtD
Guanabenz—Face oedema—Thalidomide—leprosy	0.00286	0.00664	CcSEcCtD
Guanabenz—Tachycardia—Dapsone—leprosy	0.00277	0.00645	CcSEcCtD
Guanabenz—Dehydration—Thalidomide—leprosy	0.00275	0.0064	CcSEcCtD
Guanabenz—Liver function test abnormal—Thalidomide—leprosy	0.00273	0.00635	CcSEcCtD
Guanabenz—Dry skin—Thalidomide—leprosy	0.00271	0.00631	CcSEcCtD
Guanabenz—Orthostatic hypotension—Thalidomide—leprosy	0.0027	0.00629	CcSEcCtD
Guanabenz—Hypokalaemia—Thalidomide—leprosy	0.00269	0.00626	CcSEcCtD
Guanabenz—Breast disorder—Thalidomide—leprosy	0.00268	0.00622	CcSEcCtD
Guanabenz—Cramp muscle—Thalidomide—leprosy	0.00267	0.0062	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00267	0.0062	CcSEcCtD
Guanabenz—Abdominal distension—Thalidomide—leprosy	0.00258	0.00599	CcSEcCtD
Guanabenz—Influenza—Thalidomide—leprosy	0.00256	0.00595	CcSEcCtD
Guanabenz—Bronchospasm—Thalidomide—leprosy	0.00252	0.00585	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Thalidomide—leprosy	0.00238	0.00553	CcSEcCtD
Guanabenz—Weight increased—Thalidomide—leprosy	0.00233	0.00541	CcSEcCtD
Guanabenz—Gastrointestinal pain—Dapsone—leprosy	0.00232	0.0054	CcSEcCtD
Guanabenz—Weight decreased—Thalidomide—leprosy	0.00231	0.00538	CcSEcCtD
Guanabenz—Hyperglycaemia—Thalidomide—leprosy	0.00231	0.00537	CcSEcCtD
Guanabenz—Infestation—Thalidomide—leprosy	0.00228	0.0053	CcSEcCtD
Guanabenz—Infestation NOS—Thalidomide—leprosy	0.00228	0.0053	CcSEcCtD
Guanabenz—Abdominal pain—Dapsone—leprosy	0.00225	0.00522	CcSEcCtD
Guanabenz—Body temperature increased—Dapsone—leprosy	0.00225	0.00522	CcSEcCtD
Guanabenz—Oedema peripheral—Thalidomide—leprosy	0.00202	0.00469	CcSEcCtD
Guanabenz—Erythema multiforme—Thalidomide—leprosy	0.00194	0.0045	CcSEcCtD
Guanabenz—Eye disorder—Thalidomide—leprosy	0.00191	0.00445	CcSEcCtD
Guanabenz—Tinnitus—Thalidomide—leprosy	0.00191	0.00444	CcSEcCtD
Guanabenz—Immune system disorder—Thalidomide—leprosy	0.00185	0.0043	CcSEcCtD
Guanabenz—Mediastinal disorder—Thalidomide—leprosy	0.00185	0.00429	CcSEcCtD
Guanabenz—Chills—Thalidomide—leprosy	0.00184	0.00427	CcSEcCtD
Guanabenz—Vomiting—Dapsone—leprosy	0.00181	0.0042	CcSEcCtD
Guanabenz—Malnutrition—Thalidomide—leprosy	0.00178	0.00414	CcSEcCtD
Guanabenz—Headache—Dapsone—leprosy	0.00178	0.00414	CcSEcCtD
Guanabenz—Flatulence—Thalidomide—leprosy	0.00176	0.00408	CcSEcCtD
Guanabenz—Tension—Thalidomide—leprosy	0.00175	0.00407	CcSEcCtD
Guanabenz—Nervousness—Thalidomide—leprosy	0.00173	0.00403	CcSEcCtD
Guanabenz—Back pain—Thalidomide—leprosy	0.00172	0.00401	CcSEcCtD
Guanabenz—Muscle spasms—Thalidomide—leprosy	0.00171	0.00398	CcSEcCtD
Guanabenz—Nausea—Dapsone—leprosy	0.00169	0.00392	CcSEcCtD
Guanabenz—Vision blurred—Thalidomide—leprosy	0.00168	0.00391	CcSEcCtD
Guanabenz—Ill-defined disorder—Thalidomide—leprosy	0.00165	0.00385	CcSEcCtD
Guanabenz—Anaemia—Thalidomide—leprosy	0.00165	0.00383	CcSEcCtD
Guanabenz—Agitation—Thalidomide—leprosy	0.00164	0.00381	CcSEcCtD
Guanabenz—Angioedema—Thalidomide—leprosy	0.00163	0.00379	CcSEcCtD
Guanabenz—Malaise—Thalidomide—leprosy	0.00161	0.00374	CcSEcCtD
Guanabenz—Syncope—Thalidomide—leprosy	0.0016	0.00372	CcSEcCtD
Guanabenz—Leukopenia—Thalidomide—leprosy	0.0016	0.00371	CcSEcCtD
Guanabenz—Loss of consciousness—Thalidomide—leprosy	0.00157	0.00364	CcSEcCtD
Guanabenz—Cough—Thalidomide—leprosy	0.00156	0.00362	CcSEcCtD
Guanabenz—Hypertension—Thalidomide—leprosy	0.00154	0.00358	CcSEcCtD
Guanabenz—Arthralgia—Thalidomide—leprosy	0.00152	0.00353	CcSEcCtD
Guanabenz—Myalgia—Thalidomide—leprosy	0.00152	0.00353	CcSEcCtD
Guanabenz—Chest pain—Thalidomide—leprosy	0.00152	0.00353	CcSEcCtD
Guanabenz—Anxiety—Thalidomide—leprosy	0.00151	0.00352	CcSEcCtD
Guanabenz—Discomfort—Thalidomide—leprosy	0.0015	0.00349	CcSEcCtD
Guanabenz—Dry mouth—Thalidomide—leprosy	0.00148	0.00345	CcSEcCtD
Guanabenz—Confusional state—Thalidomide—leprosy	0.00147	0.00341	CcSEcCtD
Guanabenz—Oedema—Thalidomide—leprosy	0.00145	0.00338	CcSEcCtD
Guanabenz—Infection—Thalidomide—leprosy	0.00145	0.00336	CcSEcCtD
Guanabenz—Shock—Thalidomide—leprosy	0.00143	0.00333	CcSEcCtD
Guanabenz—Nervous system disorder—Thalidomide—leprosy	0.00143	0.00332	CcSEcCtD
Guanabenz—Thrombocytopenia—Thalidomide—leprosy	0.00142	0.00331	CcSEcCtD
Guanabenz—Tachycardia—Thalidomide—leprosy	0.00142	0.0033	CcSEcCtD
Guanabenz—Skin disorder—Thalidomide—leprosy	0.00141	0.00329	CcSEcCtD
Guanabenz—Anorexia—Thalidomide—leprosy	0.00139	0.00322	CcSEcCtD
Guanabenz—Hypotension—Thalidomide—leprosy	0.00136	0.00316	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Thalidomide—leprosy	0.00133	0.00308	CcSEcCtD
Guanabenz—Paraesthesia—Thalidomide—leprosy	0.00131	0.00304	CcSEcCtD
Guanabenz—Dyspnoea—Thalidomide—leprosy	0.0013	0.00302	CcSEcCtD
Guanabenz—Dyspepsia—Thalidomide—leprosy	0.00128	0.00298	CcSEcCtD
Guanabenz—Decreased appetite—Thalidomide—leprosy	0.00126	0.00294	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Thalidomide—leprosy	0.00126	0.00292	CcSEcCtD
Guanabenz—Fatigue—Thalidomide—leprosy	0.00125	0.00292	CcSEcCtD
Guanabenz—Pain—Thalidomide—leprosy	0.00124	0.00289	CcSEcCtD
Guanabenz—Constipation—Thalidomide—leprosy	0.00124	0.00289	CcSEcCtD
Guanabenz—Feeling abnormal—Thalidomide—leprosy	0.0012	0.00279	CcSEcCtD
Guanabenz—Gastrointestinal pain—Thalidomide—leprosy	0.00119	0.00277	CcSEcCtD
Guanabenz—Urticaria—Thalidomide—leprosy	0.00116	0.00269	CcSEcCtD
Guanabenz—Abdominal pain—Thalidomide—leprosy	0.00115	0.00267	CcSEcCtD
Guanabenz—Body temperature increased—Thalidomide—leprosy	0.00115	0.00267	CcSEcCtD
Guanabenz—Hypersensitivity—Thalidomide—leprosy	0.00107	0.00249	CcSEcCtD
Guanabenz—Asthenia—Thalidomide—leprosy	0.00104	0.00243	CcSEcCtD
Guanabenz—Pruritus—Thalidomide—leprosy	0.00103	0.00239	CcSEcCtD
Guanabenz—Diarrhoea—Thalidomide—leprosy	0.000995	0.00231	CcSEcCtD
Guanabenz—Dizziness—Thalidomide—leprosy	0.000962	0.00224	CcSEcCtD
Guanabenz—Vomiting—Thalidomide—leprosy	0.000925	0.00215	CcSEcCtD
Guanabenz—Rash—Thalidomide—leprosy	0.000917	0.00213	CcSEcCtD
Guanabenz—Dermatitis—Thalidomide—leprosy	0.000917	0.00213	CcSEcCtD
Guanabenz—Headache—Thalidomide—leprosy	0.000911	0.00212	CcSEcCtD
Guanabenz—Nausea—Thalidomide—leprosy	0.000864	0.00201	CcSEcCtD
